UY31107A1 - PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS. - Google Patents
PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS.Info
- Publication number
- UY31107A1 UY31107A1 UY31107A UY31107A UY31107A1 UY 31107 A1 UY31107 A1 UY 31107A1 UY 31107 A UY31107 A UY 31107A UY 31107 A UY31107 A UY 31107A UY 31107 A1 UY31107 A1 UY 31107A1
- Authority
- UY
- Uruguay
- Prior art keywords
- treatment
- agent
- pharmaceutical composition
- combination
- urinary infections
- Prior art date
Links
- 239000004599 antimicrobial Substances 0.000 title abstract 2
- 239000003963 antioxidant agent Substances 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 230000002485 urinary effect Effects 0.000 title 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 4
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 abstract 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- 235000010323 ascorbic acid Nutrition 0.000 abstract 1
- 239000011668 ascorbic acid Substances 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 229960003405 ciprofloxacin Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000011885 synergistic combination Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 208000019206 urinary tract infection Diseases 0.000 abstract 1
- 235000019154 vitamin C Nutrition 0.000 abstract 1
- 239000011718 vitamin C Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion se refiere a una composicion farmacéutica compuesta por la combinacion sinérgica de un agente antimicrobiano, conocido como: Ciprofloxacino y un agente antioxidante, tal como:Acido Ascorbico (Vitamina C), además de excipientes farmacéuticamente adeptables, mismos que se encuentran formulados en una sola unidad de dosis para ser administrada por vía oral, utilizada para el tratamiento de Infecciones urinarias, la cual proporciona un mayor efecto terapéutico, un incremento en el apego por el tratamiento y la reduccion de la infeccion en menor tiempo.The present invention relates to a pharmaceutical composition composed of the synergistic combination of an antimicrobial agent, known as: Ciprofloxacin and an antioxidant agent, such as: Ascorbic Acid (Vitamin C), in addition to pharmaceutically suitable excipients, which are formulated in a single dose unit to be administered orally, used for the treatment of urinary infections, which provides a greater therapeutic effect, an increase in the attachment for the treatment and the reduction of the infection in less time.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY31107A UY31107A1 (en) | 2008-05-27 | 2008-05-27 | PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UY31107A UY31107A1 (en) | 2008-05-27 | 2008-05-27 | PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY31107A1 true UY31107A1 (en) | 2008-11-28 |
Family
ID=40336328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY31107A UY31107A1 (en) | 2008-05-27 | 2008-05-27 | PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS. |
Country Status (1)
| Country | Link |
|---|---|
| UY (1) | UY31107A1 (en) |
-
2008
- 2008-05-27 UY UY31107A patent/UY31107A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP078023A (en) | ACTIVE PHARMACEUTICAL INGREDIENT BASED ON CANABINOID | |
| NZ604029A (en) | Methods of treating bladder cancer | |
| MX2022014313A (en) | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS WITH CONTROLLED ABSORPTION PROFILE. | |
| CO6251259A2 (en) | PHARMACEUTICAL FORMULATIONS OF ESTRIOL IN LOW DOSE | |
| AR048705A1 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SEXUAL DISORDERS II | |
| MX2015017307A (en) | USE OF PRIDOPIDINE IN HIGH DOSE FOR THE TREATMENT OF HUNTINGTON'S DISEASE. | |
| MX343215B (en) | Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents. | |
| MX2010003642A (en) | Vaccine nanotechnology. | |
| WO2015085143A3 (en) | Therapeutic agents for skin diseases and conditions | |
| MX2010009623A (en) | 1-benzyl-3-hydroxymethylindazoiî¹e derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1. | |
| CL2019002172A1 (en) | Therapeutic agent for liver diseases. | |
| MX2010009625A (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40. | |
| MX2010009624A (en) | 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1. | |
| HRP20192189T1 (en) | Dosage forms and therapeutic uses l-4-chlorokynurenine | |
| CO2019004004A2 (en) | Pharmaceutical composition and method for the treatment of non-alcoholic fatty liver disease | |
| CO6640318A2 (en) | Oral dosage forms of bendamustine | |
| MX2020005006A (en) | Coumarin derivative for therapy or prophylaxis of a cell proliferative disorder. | |
| UY30847A1 (en) | USE OF DIANHYDROHEXITE MONONITRATE DERIVATIVES AS AGENTS FOR THE TREATMENT OF INTESTINAL DISORDERS | |
| AR066666A1 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-CONVULSIVING AGENT | |
| ECSP099733A (en) | PHARMACEUTICAL COMPOSITION UNDERSTANDING THE COMBINATION OF THE CIPROFLOXACINE ANTIMICROBIAL AGENT AND THE ASCORBIC ACID ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTION | |
| AR075866A1 (en) | A DOSE OF AVE5026 FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE RENAL DETERIORATION. USE. PHARMACEUTICAL COMPOSITION | |
| RU2013105513A (en) | Derivatives of 1-aminoalkylcyclohexane for the treatment of inflammatory skin diseases | |
| PE20130308A1 (en) | METHODS TO TREAT RECURRING BACTERIAL INFECTIONS | |
| UY31107A1 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS. | |
| UY33468A (en) | THERAPEUTIC AGENT OF SUSTAINED LIBERATION FOR HYPERTENSION AND RENAL DYSFUNCTION |